D. E. Shaw & Co., Inc. Liva Nova PLC Transaction History

D. E. Shaw & Co., Inc.

$114 Billion
Q1 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Liva Nova PLC stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 269,955 shares of LIVN stock, worth $14.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

269,955

Previous 225,946 19.48%

Holding current value

$14.3 Million

Previous $11.7 Million 29.18%

% of portfolio

0.01%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$48.6 - $57.12 $2.14 Million - $2.51 Million	44,009 Added 19.48%	269,955 $15.1 Million
Q4 2023 Feb 14, 2024	SELL	$43.45 - $53.66 $2.58 Million - $3.19 Million	-59,419 Reduced 20.82%	225,946 $11.7 Million
Q3 2023 Nov 14, 2023	SELL	$50.12 - $58.87 $5.15 Million - $6.04 Million	-102,655 Reduced 26.46%	285,365 $15.1 Million
Q2 2023 Aug 14, 2023	SELL	$42.28 - $51.43 $3.23 Million - $3.93 Million	-76,446 Reduced 16.46%	388,020 $20 Million
Q1 2023 May 15, 2023	BUY	$40.84 - $58.14 $7.44 Million - $10.6 Million	182,074 Added 64.48%	464,466 $20.2 Million

Q4 2022 Feb 14, 2023	BUY	$43.88 - $56.16 $5.78 Million - $7.4 Million	131,830 Added 87.56%	282,392 $15.7 Million
Q3 2022 Nov 14, 2022	BUY	$48.37 - $66.5 $3.43 Million - $4.72 Million	71,014 Added 89.27%	150,562 $7.64 Million
Q2 2022 Aug 15, 2022	SELL	$57.25 - $86.63 $338,118 - $511,636	-5,906 Reduced 6.91%	79,548 $4.97 Million
Q1 2022 May 16, 2022	BUY	$71.02 - $86.99 $2.84 Million - $3.47 Million	39,946 Added 87.78%	85,454 $6.99 Million
Q4 2021 Feb 14, 2022	SELL	$76.72 - $92.68 $1.46 Million - $1.77 Million	-19,068 Reduced 29.53%	45,508 $3.98 Million
Q3 2021 Nov 15, 2021	BUY	$76.02 - $88.62 $2.67 Million - $3.11 Million	35,122 Added 119.24%	64,576 $5.11 Million
Q2 2021 Aug 16, 2021	SELL	$73.44 - $87.01 $980,570 - $1.16 Million	-13,352 Reduced 31.19%	29,454 $2.48 Million
Q1 2021 May 17, 2021	SELL	$62.9 - $82.41 $2.94 Million - $3.86 Million	-46,802 Reduced 52.23%	42,806 $3.16 Million
Q4 2020 Feb 16, 2021	SELL	$46.01 - $68.74 $7.34 Million - $11 Million	-159,526 Reduced 64.03%	89,608 $5.93 Million
Q3 2020 Nov 16, 2020	SELL	$41.91 - $57.81 $12 Million - $16.5 Million	-286,237 Reduced 53.47%	249,134 $11.3 Million
Q2 2020 Aug 14, 2020	BUY	$39.87 - $56.9 $248,908 - $355,226	6,243 Added 1.18%	535,371 $25.8 Million
Q1 2020 May 15, 2020	SELL	$34.22 - $76.49 $4 Million - $8.94 Million	-116,943 Reduced 18.1%	529,128 $23.9 Million
Q4 2019 Feb 14, 2020	BUY	$68.92 - $85.27 $9.49 Million - $11.7 Million	137,629 Added 27.07%	646,071 $48.7 Million
Q3 2019 Nov 14, 2019	BUY	$71.74 - $86.35 $8.34 Million - $10 Million	116,293 Added 29.66%	508,442 $37.5 Million
Q2 2019 Aug 14, 2019	BUY	$66.45 - $97.36 $24.6 Million - $36 Million	369,885 Added 1661.36%	392,149 $28.2 Million
Q1 2019 May 15, 2019	SELL	$86.15 - $100.49 $1.57 Million - $1.83 Million	-18,258 Reduced 45.06%	22,264 $2.17 Million
Q4 2018 Feb 14, 2019	SELL	$84.14 - $125.42 $2.19 Million - $3.26 Million	-25,993 Reduced 39.08%	40,522 $3.71 Million
Q3 2018 Nov 14, 2018	SELL	$101.02 - $130.95 $1.15 Million - $1.49 Million	-11,405 Reduced 14.64%	66,515 $8.25 Million
Q2 2018 Aug 14, 2018	SELL	$81.75 - $105.37 $4.35 Million - $5.61 Million	-53,267 Reduced 40.6%	77,920 $7.78 Million
Q1 2018 May 15, 2018	BUY	$79.95 - $89.74 $975,230 - $1.09 Million	12,198 Added 10.25%	131,187 $11.6 Million
Q4 2017 Feb 14, 2018	BUY	$71.8 - $88.21 $5.26 Million - $6.46 Million	73,209 Added 159.91%	118,989 $9.51 Million
Q3 2017 Nov 14, 2017	BUY	$60.32 - $70.06 $2.76 Million - $3.21 Million	45,780	45,780 $3.21 Million

Others Institutions Holding LIVN

# of Institutions

252

Shares Held

56.2M

Call Options Held

367K

Put Options Held

597K

View Full List

About LivaNova PLC

Ticker LIVN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 53,545,700
Market Cap $2.83B
Description
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...

More about LIVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account